U.S. markets close in 3 hours 19 minutes
  • S&P 500

    4,353.15
    +3.22 (+0.07%)
     
  • Dow 30

    34,298.81
    +130.72 (+0.38%)
     
  • Nasdaq

    13,481.49
    -60.63 (-0.45%)
     
  • Russell 2000

    1,956.11
    -20.36 (-1.03%)
     
  • Crude Oil

    86.89
    -0.46 (-0.53%)
     
  • Gold

    1,792.20
    -37.50 (-2.05%)
     
  • Silver

    22.65
    -1.16 (-4.88%)
     
  • EUR/USD

    1.1151
    -0.0094 (-0.84%)
     
  • 10-Yr Bond

    1.7920
    -0.0560 (-3.03%)
     
  • GBP/USD

    1.3383
    -0.0080 (-0.59%)
     
  • USD/JPY

    115.3100
    +0.6500 (+0.57%)
     
  • BTC-USD

    36,270.29
    -1,852.21 (-4.86%)
     
  • CMC Crypto 200

    830.14
    +10.64 (+1.30%)
     
  • FTSE 100

    7,554.31
    +84.53 (+1.13%)
     
  • Nikkei 225

    26,170.30
    -841.03 (-3.11%)
     

CLASS ACTION UPDATE for NERV, QIWI and OTGLY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·4 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • QIWI
  • NERV
  • OTGLF
  • OTGLY

NEW YORK, NY / ACCESSWIRE / February 5, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

NERV Shareholders Click Here: https://www.zlk.com/pslra-1/minerva-neurosciences-inc-loss-submission-form?prid=12714&wire=1
QIWI Shareholders Click Here: https://www.zlk.com/pslra-1/qiwi-plc-information-request-form?prid=12714&wire=1
OTGLY Shareholders Click Here: https://www.zlk.com/pslra-1/cd-projekt-s-a-loss-submission-form?prid=12714&wire=1

* ADDITIONAL INFORMATION BELOW *

Minerva Neurosciences, Inc. (NASDAQ:NERV)

NERV Lawsuit on behalf of: investors who purchased May 15, 2017 - November 30, 2020
Lead Plaintiff Deadline : February 8, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/minerva-neurosciences-inc-loss-submission-form?prid=12714&wire=1

According to the filed complaint, during the class period, Minerva Neurosciences, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the truth about the feedback received from the FDA concerning the “end-of-Phase 2” meeting; (ii) the Phase 2b study did not use the commercial formulation of roluperidone and was conducted solely outside of the United States; (iii) the failure of the Phase 3 study to meet its primary and key secondary endpoints rendered that study incapable of supporting substantial evidence of effectiveness; (iv) the Company's plan to use the combination of the Phase 2b and Phase 3 studies would be “highly unlikely” to support the submission of an NDA; (v) reliance on these two trials in the submission of an NDA would lead to “substantial review issues” because the trials were inadequate and not well-controlled; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.

Qiwi plc (NASDAQ:QIWI)

QIWI Lawsuit on behalf of: investors who purchased March 28, 2019 - December 9, 2020
Lead Plaintiff Deadline : February 9, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/qiwi-plc-information-request-form?prid=12714&wire=1

According to the filed complaint, during the class period, Qiwi plc made materially false and/or misleading statements and/or failed to disclose that: (1) Qiwi's internal controls related to reporting and record-keeping were ineffective; (2) consequently, the Central Bank of Russia would impose a monetary fine upon the Company and impose restrictions upon the Company's ability to make payments to foreign merchants and transfer money to pre-paid cards; and (3) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

CD Projekt S.A. (OTC PINK:OTGLY)

OTGLY Lawsuit on behalf of: investors who purchased January 16, 2020 - December 17, 2020
Lead Plaintiff Deadline : February 22, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/cd-projekt-s-a-loss-submission-form?prid=12714&wire=1

According to the filed complaint, during the class period, CD Projekt S.A. made materially false and/or misleading statements and/or failed to disclose that: Throughout the class period, defendants were materially false and/or misleading because they misrepresented and failed to disclose the following adverse facts pertaining to the Company's business, operations and prospects, which were known to Defendants or recklessly disregarded by them. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Cyberpunk 2077 was virtually unplayable on the current-generation Xbox or Playstation systems due to an enormous number of bugs; (2) as a result, Sony would remove Cyberpunk 2077 from the Playstation store, and Sony, Microsoft and the Company would be forced to offer full refunds for the game; (3) consequently, the Company would suffer reputational and pecuniary harm; and (4) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com/

SOURCE: Levi & Korsinsky, LLP



View source version on accesswire.com:
https://www.accesswire.com/628155/CLASS-ACTION-UPDATE-for-NERV-QIWI-and-OTGLY-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders